TAYLOR MORRISON HOME CORP (TMHC) Stock Fundamental Analysis

NYSE:TMHC • US87724P1066

67.43 USD
-0.66 (-0.97%)
At close: Feb 18, 2026
67.43 USD
0 (0%)
After Hours: 2/18/2026, 8:04:37 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

5

Taking everything into account, TMHC scores 5 out of 10 in our fundamental rating. TMHC was compared to 60 industry peers in the Household Durables industry. TMHC has an excellent profitability rating, but there are some minor concerns on its financial health. TMHC is cheap, but on the other hand it scores bad on growth. These ratings would make TMHC suitable for value investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • In the past year TMHC was profitable.
  • TMHC had a positive operating cash flow in the past year.
  • Each year in the past 5 years TMHC has been profitable.
  • TMHC had a positive operating cash flow in 4 of the past 5 years.
TMHC Yearly Net Income VS EBIT VS OCF VS FCFTMHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B

1.2 Ratios

  • TMHC has a Return On Assets of 8.84%. This is in the better half of the industry: TMHC outperforms 78.33% of its industry peers.
  • The Return On Equity of TMHC (13.76%) is better than 71.67% of its industry peers.
  • TMHC has a better Return On Invested Capital (10.88%) than 73.33% of its industry peers.
  • TMHC had an Average Return On Invested Capital over the past 3 years of 10.69%. This is in line with the industry average of 9.21%.
  • The last Return On Invested Capital (10.88%) for TMHC is above the 3 year average (10.69%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 8.84%
ROE 13.76%
ROIC 10.88%
ROA(3y)8.77%
ROA(5y)9.27%
ROE(3y)13.98%
ROE(5y)16.31%
ROIC(3y)10.69%
ROIC(5y)11.14%
TMHC Yearly ROA, ROE, ROICTMHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • TMHC has a Profit Margin of 10.16%. This is amongst the best in the industry. TMHC outperforms 85.00% of its industry peers.
  • TMHC's Profit Margin has improved in the last couple of years.
  • TMHC has a Operating Margin of 14.53%. This is amongst the best in the industry. TMHC outperforms 88.33% of its industry peers.
  • TMHC's Operating Margin has improved in the last couple of years.
  • TMHC has a Gross Margin (23.91%) which is comparable to the rest of the industry.
  • TMHC's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 14.53%
PM (TTM) 10.16%
GM 23.91%
OM growth 3Y-6.84%
OM growth 5Y13.63%
PM growth 3Y-9.03%
PM growth 5Y19.4%
GM growth 3Y-2.77%
GM growth 5Y6.54%
TMHC Yearly Profit, Operating, Gross MarginsTMHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so TMHC is still creating some value.
  • Compared to 1 year ago, TMHC has less shares outstanding
  • TMHC has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for TMHC is higher compared to a year ago.
TMHC Yearly Shares OutstandingTMHC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
TMHC Yearly Total Debt VS Total AssetsTMHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

  • An Altman-Z score of 3.90 indicates that TMHC is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of TMHC (3.90) is comparable to the rest of the industry.
  • TMHC has a debt to FCF ratio of 3.84. This is a good value and a sign of high solvency as TMHC would need 3.84 years to pay back of all of its debts.
  • TMHC has a Debt to FCF ratio (3.84) which is in line with its industry peers.
  • A Debt/Equity ratio of 0.35 indicates that TMHC is not too dependend on debt financing.
  • With a Debt to Equity ratio value of 0.35, TMHC perfoms like the industry average, outperforming 43.33% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF 3.84
Altman-Z 3.9
ROIC/WACC1.21
WACC9%
TMHC Yearly LT Debt VS Equity VS FCFTMHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.3 Liquidity

  • TMHC has a Current Ratio of 6.43. This indicates that TMHC is financially healthy and has no problem in meeting its short term obligations.
  • With a decent Current ratio value of 6.43, TMHC is doing good in the industry, outperforming 78.33% of the companies in the same industry.
  • TMHC has a Quick Ratio of 6.43. This is a bad value and indicates that TMHC is not financially healthy enough and could expect problems in meeting its short term obligations.
  • TMHC's Quick ratio of 0.58 is on the low side compared to the rest of the industry. TMHC is outperformed by 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 6.43
Quick Ratio 0.58
TMHC Yearly Current Assets VS Current LiabilitesTMHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. Growth

3.1 Past

  • TMHC shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -7.51%.
  • Measured over the past years, TMHC shows a very strong growth in Earnings Per Share. The EPS has been growing by 23.33% on average per year.
  • The Revenue has decreased by -0.57% in the past year.
  • TMHC shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.79% yearly.
EPS 1Y (TTM)-7.51%
EPS 3Y-5.31%
EPS 5Y23.33%
EPS Q2Q%-23.48%
Revenue 1Y (TTM)-0.57%
Revenue growth 3Y-0.42%
Revenue growth 5Y5.79%
Sales Q2Q%-9.74%

3.2 Future

  • The Earnings Per Share is expected to grow by 2.57% on average over the next years.
  • The Revenue is expected to decrease by -3.50% on average over the next years.
EPS Next Y-15.13%
EPS Next 2Y2.57%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-14.69%
Revenue Next 2Y-3.5%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
TMHC Yearly Revenue VS EstimatesTMHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B
TMHC Yearly EPS VS EstimatesTMHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8

More info and screens

Find the best growth stocksShow best growing peers

7

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 8.69, the valuation of TMHC can be described as very reasonable.
  • Based on the Price/Earnings ratio, TMHC is valued cheaply inside the industry as 86.67% of the companies are valued more expensively.
  • When comparing the Price/Earnings ratio of TMHC to the average of the S&P500 Index (27.27), we can say TMHC is valued rather cheaply.
  • A Price/Forward Earnings ratio of 10.24 indicates a reasonable valuation of TMHC.
  • Based on the Price/Forward Earnings ratio, TMHC is valued cheaply inside the industry as 86.67% of the companies are valued more expensively.
  • TMHC is valuated cheaply when we compare the Price/Forward Earnings ratio to 28.16, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 8.69
Fwd PE 10.24
TMHC Price Earnings VS Forward Price EarningsTMHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • TMHC's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. TMHC is cheaper than 75.00% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, TMHC is valued cheaply inside the industry as 81.67% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 11.56
EV/EBITDA 6.69
TMHC Per share dataTMHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

  • TMHC has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.37
EPS Next 2Y2.57%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for TMHC!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

TAYLOR MORRISON HOME CORP

NYSE:TMHC (2/18/2026, 8:04:37 PM)

After market: 67.43 0 (0%)

67.43

-0.66 (-0.97%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)02-11
Earnings (Next)04-21
Inst Owners100.87%
Inst Owner Change0.1%
Ins Owners0.49%
Ins Owner Change-7.5%
Market Cap6.59B
Revenue(TTM)8.12B
Net Income(TTM)850.94M
Analysts78.75
Price Target77.23 (14.53%)
Short Float %5.1%
Short Ratio4.63
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.92%
Min EPS beat(2)-2.85%
Max EPS beat(2)1.01%
EPS beat(4)2
Avg EPS beat(4)0.19%
Min EPS beat(4)-5.59%
Max EPS beat(4)8.2%
EPS beat(8)5
Avg EPS beat(8)1.44%
EPS beat(12)7
Avg EPS beat(12)4.86%
EPS beat(16)11
Avg EPS beat(16)6.37%
Revenue beat(2)1
Avg Revenue beat(2)1.09%
Min Revenue beat(2)-2.35%
Max Revenue beat(2)4.54%
Revenue beat(4)3
Avg Revenue beat(4)1.14%
Min Revenue beat(4)-2.35%
Max Revenue beat(4)4.54%
Revenue beat(8)6
Avg Revenue beat(8)1.28%
Revenue beat(12)10
Avg Revenue beat(12)3.22%
Revenue beat(16)12
Avg Revenue beat(16)2.2%
PT rev (1m)1.79%
PT rev (3m)3.07%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.02%
EPS NY rev (1m)0%
EPS NY rev (3m)0.01%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.48%
Valuation
Industry RankSector Rank
PE 8.69
Fwd PE 10.24
P/S 0.79
P/FCF 11.56
P/OCF 10.82
P/B 1.07
P/tB 1.19
EV/EBITDA 6.69
EPS(TTM)7.76
EY11.51%
EPS(NY)6.59
Fwd EY9.77%
FCF(TTM)5.83
FCFY8.65%
OCF(TTM)6.23
OCFY9.24%
SpS85.73
BVpS63.28
TBVpS56.49
PEG (NY)N/A
PEG (5Y)0.37
Graham Number105.11
Profitability
Industry RankSector Rank
ROA 8.84%
ROE 13.76%
ROCE 14.26%
ROIC 10.88%
ROICexc 11.38%
ROICexgc 12.38%
OM 14.53%
PM (TTM) 10.16%
GM 23.91%
FCFM 6.8%
ROA(3y)8.77%
ROA(5y)9.27%
ROE(3y)13.98%
ROE(5y)16.31%
ROIC(3y)10.69%
ROIC(5y)11.14%
ROICexc(3y)11.72%
ROICexc(5y)12.31%
ROICexgc(3y)13.29%
ROICexgc(5y)14.07%
ROCE(3y)14.01%
ROCE(5y)14.6%
ROICexgc growth 3Y-14.33%
ROICexgc growth 5Y13.76%
ROICexc growth 3Y-12.76%
ROICexc growth 5Y14.64%
OM growth 3Y-6.84%
OM growth 5Y13.63%
PM growth 3Y-9.03%
PM growth 5Y19.4%
GM growth 3Y-2.77%
GM growth 5Y6.54%
F-Score7
Asset Turnover0.87
Health
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF 3.84
Debt/EBITDA 1.74
Cap/Depr 100.08%
Cap/Sales 0.47%
Interest Coverage 250
Cash Conversion 48.49%
Profit Quality 66.97%
Current Ratio 6.43
Quick Ratio 0.58
Altman-Z 3.9
F-Score7
WACC9%
ROIC/WACC1.21
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-7.51%
EPS 3Y-5.31%
EPS 5Y23.33%
EPS Q2Q%-23.48%
EPS Next Y-15.13%
EPS Next 2Y2.57%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.57%
Revenue growth 3Y-0.42%
Revenue growth 5Y5.79%
Sales Q2Q%-9.74%
Revenue Next Year-14.69%
Revenue Next 2Y-3.5%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y4.7%
EBIT growth 3Y-7.23%
EBIT growth 5Y20.21%
EBIT Next Year-12.03%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y3775.83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y2123.3%
OCF growth 3YN/A
OCF growth 5YN/A

TAYLOR MORRISON HOME CORP / TMHC FAQ

What is the ChartMill fundamental rating of TAYLOR MORRISON HOME CORP (TMHC) stock?

ChartMill assigns a fundamental rating of 5 / 10 to TMHC.


What is the valuation status for TMHC stock?

ChartMill assigns a valuation rating of 7 / 10 to TAYLOR MORRISON HOME CORP (TMHC). This can be considered as Undervalued.


How profitable is TAYLOR MORRISON HOME CORP (TMHC) stock?

TAYLOR MORRISON HOME CORP (TMHC) has a profitability rating of 8 / 10.


What is the earnings growth outlook for TAYLOR MORRISON HOME CORP?

The Earnings per Share (EPS) of TAYLOR MORRISON HOME CORP (TMHC) is expected to decline by -15.13% in the next year.